Synovus Financial (NYSE:SNV) announces its next round of earnings this Tuesday, July 20. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings announcement.
GXO's 2027 Financial Targets
8-12% organic revenue CAGR (2021 to 2027) to approximately $17 billion of revenue;
Approximately 17% Adjusted EBITDA CAGR to
4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.28) per share. This is a 90.41 percent increase over losses of $(2.92) per share from the same period last year. The company reported $14.58
Someone with a lot of money to spend has taken a bullish stance on Wells Fargo (NYSE:WFC).
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.